Back to briefing
Research France, Belgium

Interest of Salivary Signature of Endometriosis in the Healthcare Pathway of Adolescent

The ADOmiARN study is a multicentre, prospective, longitudinal, non-interventional observational study conducted in France and Belgium. It evaluates the in vitro diagnostic medical device EndoTest® in adolescents aged 10 to 19 years with suspected or formally diagnosed endometriosis, while keeping the usual care pathway unchanged. The study collects saliva samples and self-reported symptom and quality-of-life questionnaires without altering standard treatments or diagnostic examinations.

Published
3 Jul 2023
2 min read 1 source
Intelligence brief
France, Belgium / Research
CH

The ADOmiARN study is a multicentre, prospective, longitudinal, non-interventional observational study conducted in France and Belgium. It evaluates the in vitro diagnostic medical device EndoTest® in adolescents aged 10 to 19 years with suspected or formally diagnosed endometriosis, while keeping the usual care pathway unchanged. The study collects saliva samples and self-reported symptom and quality-of-life questionnaires without altering standard treatments or diagnostic examinations.

Why it matters

The non‑invasive salivary diagnostic approach explored in this study could inform the development of AI‑driven diagnostic tools within Swiss healthcare systems.

Primary source record
ClinicalTrials.gov

Original source record. Open the original record to verify the underlying announcement.

Your privacy choices

Allow optional Google Analytics to help us understand how the site is used. Analytics stays off unless you accept. Privacy details